GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
1.434
-0.076 (-5.03%)
At close: Mar 9, 2026, 4:00 PM EDT
1.421
-0.013 (-0.89%)
After-hours: Mar 9, 2026, 7:38 PM EDT
GlucoTrack Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
1.45M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 87.37M |
| Retractable Technologies | 37.90M |
| Bionano Genomics | 28.72M |
| Precision Optics Corporation | 24.42M |
| Jin Medical International | 20.69M |
| Ekso Bionics Holdings | 12.80M |
| NEXGEL | 11.67M |
| Milestone Scientific | 8.93M |
GCTK News
- 5 weeks ago - Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform - GlobeNewsWire
- 2 months ago - Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor - GlobeNewsWire
- 4 months ago - Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights - GlobeNewsWire
- 4 months ago - Glucotrack, Inc. Encourages Shareholders to Vote - GlobeNewsWire
- 4 months ago - Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team - GlobeNewsWire
- 4 months ago - Glucotrack, Inc. Reminds Shareholders to Vote - GlobeNewsWire
- 6 months ago - Glucotrack to Participate in the Q3 Virtual Investor Summit - GlobeNewsWire
- 7 months ago - Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire